Loading organizations...
Key people at Ohio Tech Angel Fund.
Ohio TechAngel Funds (OTAF) operates as a prominent group of for-profit investor funds providing essential seed and early-stage capital to technology companies. Primarily focusing on innovations within information technology, life sciences, and advanced materials, OTAF strategically invests in high-potential ventures. The organization employs a multi-fund structure, including sidecar funds, and benefits from management expertise provided by Rev1 Ventures, collectively forming a substantial funding mechanism for nascent enterprises.
The fund was established in 2004 by John O. Huston, who launched the inaugural fund with a core group of 50 investors. Huston's vision centered on creating a robust angel investment ecosystem dedicated to the commercialization of technology and the growth of early-stage companies across Ohio. This foundational effort aimed to address a critical funding gap for promising local innovations.
Ohio TechAngel Funds primarily serves early-stage technology companies located within the state, acting as a crucial capital partner. With a broad base of over 340 contributing investors, the fund is currently deploying its fifth investment vehicle. Its ongoing mission is to cultivate a vibrant innovation economy by continually identifying and backing scalable technology solutions, ensuring sustained growth for Ohio's entrepreneurial landscape.
Key people at Ohio Tech Angel Fund.
Ohio Tech Angel Fund has 7 tracked investments across 6 companies. The latest tracked deal is $7.0M Series B in Complion in February 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 13, 2019 | Complion | $7.0M Series B | William Blake | Novel, Bill Baumel |
| May 8, 2018 | Rapchat | $1.6M Seed | — | 500 Startups, Base Ventures, M25, Ryan Helon, TechNexus Venture Collaborative |
| Aug 3, 2017 | 3Bar Biologics | $2.0M Seed | — | Carmen Innovations, Maumee Ventures, Queen City Angels, Dave Bergeron, SVG Ventures |
| Jul 18, 2012 | Neuros Medical | $3.5M Other Equity | Boston Scientific, Stephen R. Haynes | BlueTree Allied Angels, Case Tech Ventures, JumpStart Ventures, Modelvest, North Coast Ventures, Physician Investment Group, Queen City Angels, RiverVest Venture Partners |
| Aug 16, 2011 | SironRX Therapeutics | $3.4M Series A | Claiborne ("clay") Rankin | Cleveland Clinic, Early Stage Partners, Fletcher Spaght Ventures, Glengary, Novel, Xgen Ventures |
| Jun 11, 2011 | SparkBase | $3.0M Series A | — | Blue Olive Partners, North Coast Ventures |
| Oct 23, 2009 | Neuros Medical | $1.8M Series A | Claiborne ("clay") Rankin | Stephen R. Haynes, Queen City Angels |